Latest Ai Technology News

Decidr AI Industries Ltd reported a $17.2 million loss for the half-year ending December 2025, reversing a prior profit, while completing full ownership of Decidr.ai and expanding into the US market with Sugarwork Inc.

FortifAI Limited reported a 51% revenue decline but a 70% reduction in net loss for H1 FY26, alongside completing a major AI technology acquisition and securing $5 million in fresh capital.

XPON Technologies has posted a strong H1 FY26 turnaround with a 58% revenue increase and a return to net profitability, driven by strategic acquisitions and operational improvements.

FortifAI Limited has raised $5 million through a strategic placement led by a major Australian institutional fund manager, reinforcing its balance sheet and accelerating its AI development and commercialisation plans.

Alcidion has secured regulatory approval for its AI-powered clinical tool in Australia and the UK, paving the way for commercial rollout in its largest markets. This milestone strengthens its position in healthcare technology and opens new sales avenues.

Articore Group Limited reports a significant turnaround in 1HFY26 with improved profitability and margin expansion, prompting an upgrade to its FY26 EBIT guidance. The company’s strategic initiatives in marketing, supply chain, and technology are driving renewed momentum.

SEEK Limited reported robust H1 FY2026 results, powered by AI-driven product innovation and pricing, delivering strong revenue and profit growth alongside a record interim dividend. However, a significant impairment on its Zhaopin investment weighed on reported earnings.

SEEK Limited has reported a robust first half for FY2026, driven by AI-enhanced products and strategic pricing, resulting in double-digit revenue growth and a record interim dividend.

WT Financial Group Limited has reported a robust 16.1% increase in net revenue for the half-year ending December 2025, underpinned by strategic acquisitions and a pioneering joint venture. The company’s proprietary AI technology and industry consolidation efforts position it well for continued expansion.

BlinkLab has expanded its pivotal FDA 510(k) autism diagnostic trial to nine top U.S. sites, adding Drexel University ahead of the Q1 2026 study start. This move follows a successful pilot study that exceeded FDA benchmarks, positioning BlinkLab Dx 1 for regulatory clearance.

Temple & Webster reported a 20% revenue increase to $375.9 million for H1 FY26, driven by record active customers and exclusive product growth. However, profit before tax fell 25% to $9.4 million, impacted by investments in New Zealand and higher marketing spend.

Victory Metals has reported a remarkable 26-fold increase in Hafnium grade at its North Stanmore project, achieved through simple gravity separation, positioning the company as a potential key supplier of this critical defence metal.